Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

cend-

cend- is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 40
News articles 0
Drug details — cend-
Class
—
Route
—
Patents
20
Programs
40
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

cend- is an FDA-listed pharmaceutical active ingredient.

Key facts

INN cend-

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Cendakimab Phase 3 · Celgene · Eosinophilic esophagitis
  2. P170912J Phase 3 · PARItec · Adult patients with indication for conventional cardiac surg
  3. ARCT-032-02 Phase 2 · Arcturus Therapeutics · Cystic Fibrosis
  4. Cenderitide Phase 2 · CAPRICOR THERAPEUTICS · Heart Failure
  5. HM-GCG-201 Phase 2 · Alphapharm · Congenital Hyperinsulinism (CHI)
  6. STK-001 - Single Ascending Doses Phase 2 · Stoke Therapeutics · Dravet Syndrome
  7. 95597528EDI1001 Phase 1 · Janssen-Cilag International N.V · Mild to Moderate Asthma
  8. A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants Phase 1 · MSD Merck Sharp · Amyotrophic lateral sclerosis and Alzheimer’s disease

Related patents

Browse patents

  1. US 12398379

    Compositions and methods for treating ornithine transcarbamylase deficiency

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12390524

    Compositions and methods for inducing immune responses

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12290567

    Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12286395

    Method of synthesis of an ionizable cationic lipid

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12220485

    Method of making lipid-encapsulated RNA nanoparticles

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12178921

    Method of lyophilizing lipid nanoparticles

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12083224

    Lipid particles for nucleic acid delivery

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11939363

    Translatable molecules and synthesis thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11938227

    Lipid nanoparticles encapsulation of large RNA

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11939600

    Compositions and methods for treating phenylketonuria

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11759515

    Compositions and methods for inducing immune responses

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11737979

    Method of making lipid-encapsulated RNA nanoparticles

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11685906

    Compositions and methods for treating ornithine transcarbamylase deficiency

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11685921

    Molecules and agents for treating hepatitis B virus

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11407800

    Translatable molecules and synthesis thereof

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11015204

    Synthesis and structure of high potency RNA therapeutics

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10980895

    Ionizable cationic lipid for RNA delivery

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10968248

    Trinucleotide mRNA cap analogs

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10961535

    Compositions and agents against hepatitis B virus and uses thereof

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10815463

    Messenger UNA molecules and uses thereof

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cend-?

cend- is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.